Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C16H20N4O2 |
| Molecular Weight | 300.3556 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC1C(=O)N2N(C1=O)C3=C(C=CC(C)=C3)N=C2N(C)C
InChI
InChIKey=MPHPHYZQRGLTBO-UHFFFAOYSA-N
InChI=1S/C16H20N4O2/c1-5-6-11-14(21)19-13-9-10(2)7-8-12(13)17-16(18(3)4)20(19)15(11)22/h7-9,11H,5-6H2,1-4H3
| Molecular Formula | C16H20N4O2 |
| Molecular Weight | 300.3556 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
DescriptionSources: http://home.intekom.com/pharm/cont_eth/rheumox.htmlCurator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/770078
Sources: http://home.intekom.com/pharm/cont_eth/rheumox.html
Curator's Comment: description was created based on several sources, including:
https://www.ncbi.nlm.nih.gov/pubmed/770078
Azapropazone is a non-steroidal anti-inflammatory drug. It is indicated for use in the treatment of rheumatoid arthritis, osteo-arthritis and gout. Gastro-intestinal disturbances, allergic skin rashes and photosensitivity, headache, vertigo, oedema and kidney impairment may occur. Gastro-intestinal bleeding and angioedema have been reported. Pre-treatment with this drug failed to modify plasma concentrations of phenobarbitone. Brain levels of imipramine or desmethyl imipramine were unaffected 60 minutes after oral administration of imipramine.
CNS Activity
Sources: https://www.ncbi.nlm.nih.gov/pubmed/770078
Curator's Comment: Studies on the distribution of the drug revealed that low concentrations were measured in the brain.
Originator
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: WP98 Sources: DOI: 10.1007/978-94-009-0713-3_4 |
3.0 µM [IC50] | ||
Target ID: GO:0030166 Sources: DOI: 10.1007/978-94-009-0713-3_4 |
|||
Target ID: GO:0032610 Sources: DOI: 10.1007/978-94-009-0713-3_4 |
|||
Target ID: CHEMBL1929 Sources: DOI: 10.1007/978-94-009-0713-3_4 |
15.0 µM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Rheumox Approved UseRheumox is usually prescribed for people with rheumatoid arthritis |
|||
| Primary | Rheumox Approved UseIt is indicated for use in the treatment of osteo-arthritis |
|||
| Primary | Rheumox Approved UseRheumox is usually prescribed for people with acute gouty inflammation of the joints. |
Sample Use Guides
In Vivo Use Guide
Sources: http://home.intekom.com/pharm/cont_eth/rheumox.html
The usual dose is 1200 mg per day, given as 600 mg twice daily.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2158370
Azapropazone is an inhibitor of a variety of neutrophil functions (migration, aggregation, superoxide production) at 40-400 ug/ml-1
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 07:52:38 GMT 2025
by
admin
on
Wed Apr 02 07:52:38 GMT 2025
|
| Record UNII |
K2VOT966ZI
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QM01AX04
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
||
|
WHO-ATC |
M01AX04
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2276
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
K2VOT966ZI
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
SUB05638MIG
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
D001032
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
102824
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
C73074
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
13539-59-8
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
CHEMBL1565476
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
266
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
AZAPROPAZONE
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
236-913-8
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
DB07402
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
1029
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID6045408
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
38010
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
Apazone
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
m1983
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | Merck Index | ||
|
26098
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY | |||
|
100000086076
Created by
admin on Wed Apr 02 07:52:38 GMT 2025 , Edited by admin on Wed Apr 02 07:52:38 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE | |||
|
SOLVATE->ANHYDROUS |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |